Article Details

Sierra Signs Exclusive Deal with AstraZeneca for Potent BRD4 BET Inhibitor

Retrieved on: 2021-08-06 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Sierra Signs Exclusive Deal with AstraZeneca for Potent BRD4 BET Inhibitor. View article details on HISWAI: https://www.biospace.com/article/sierra-oncology-inks-exclusive-deal-with-astrazeneca-for-a-potential-treatment-for-myelofibrosis

Excerpt

Sierra Oncology, the late-stage biopharmaceutical firm specializing in treatments for rare cancers, has signed an exclusive deal to use AstraZeneca's ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up